Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Monitoring”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,459 records · Page 81Linked to original sources

Neurophysiologic monitoring in the neuroscience intensive care unit.

Neurologically critically ill patients, more often than others, are unable to communicate and, for a crucial period of time, have the vital functions of their brains hidden in the "black box" of the cranial vault behind a curtain of ambiguity and immobility. Customarily--and naively--we have relied upon beside clinical observations to pierce these barriers. Recent insights lead us to conclude that these "neurochecks" no longer suffice. This article has surveyed four major monitoring systems relied upon by neurointensivists to evaluate the pathophysiology of their patients. Of these, ICPM has the longest clinical track record. It provides a quantitative measure of the brain's capacity to withstand ICP and helps us monitor interventions to reduce it. To utilize this information intelligently requires an understanding of the principles of ICC, CPP, ICP wave morphology, and the hardware available. NICU-CEEG is a more recent introduction but, in principle, it transfers from the laboratory and operating suite to the ICU bedside, established correlations among electrophysiology, CBF, and CM. Digital EEG has allowed us to overcome significant logistical barriers and made NICU-CEEG a practical ICU tool. Early but impressive data suggest that NICU-CEEG has a significant clinical impact in patients with ACI, uncontrolled seizures, or coma. It also has revealed that NICU patients have a surprisingly high incidence of NCS, which may adversely affect their outcome. TCD has contributed greatly to diagnosis and management of SAH vasospasm. It also can be applied with benefit to patients with increased ICP, and has promising value in patients with ACI. It may prove beneficial in monitoring unstable cerebral embolization. Several bedside methods for monitoring CBF are available, but they require refinement to become true monitoring systems. These methods have revealed clinically important insights in patients with head trauma, SAH vasospasm, and ACI. Methods for directly monitoring CM and CMRo2 are improving our understanding of the brain's responses to injury, and becoming increasingly relevant to bedside management. SjvO2 can detect cerebral ischemia caused by overzealous hyperventilation and accelerated ICP. ICO holds promise as a noninvasive transcranial method for assessing Scvo2. We soon may see a scalp array of such detectors, similar to an EEG "montage," that allows us to assess multiregional Scvo2. To be useful, a clinical method should raise questions for further investigation. If the neurophysiologic monitoring systems described here provide us with some answers and lead us to ask useful new questions, they will prove their benefit to our patients.

Brain↗

[An experiment on drinking using breath alcohol monitor (Alcomed 3010) by an electrochemical method].

A drinking experiment was performed to evaluate the efficiency of a breath alcohol monitor, Alcomed 3010. The ethanol concentrations in blood and breath were determined by gas chromatography, and in particular the breath ethanol concentration was determined with the breath alcohol monitor and by gas chromatography. The results obtained by two methods were compared. Based on the blood and breath ethanol concentrations, the following conclusions were drawn reading the breath alcohol monitor. The monitor has practical merit for determination of the breath ethanol level. It is small, usable anywhere, with little error in determination. In measuring principle, tobacco and acetone did not affected levels with the meter, but methanol, n-propanol and n-butanol affected determinations with the alcohol monitor. The breath (AM)/blood (GC) ethanol ratio was 1:2555. Comparison of the values determined with the alcohol monitor and gas chromatography yielded the equation: y = 0.998 x +/- 0.012 (r = 0.994). When determinations were made on the pure ethanol gas by the meter and gas chromatograph, the equation was: y = 0.974 x +/- 0.021 (r = 0.994). It may be said therefore that the alcohol monitor is both practically and functionally excellent.

Adult↗

MONI: an intelligent database and monitoring system for surveillance of nosocomial infections.

Recording, recognition, and prevention of nosocomial infections are the primary responsibilities of the hospital infection control unit. To perform these tasks, this unit needs information from diverse sources--the patient's symptoms and signs, microbiological and virological test results, and information regarding antibiotics and treatment come from different levels of healthcare delivery. Because of the large amount of data (e.g., about 300 microbiological requests daily) a computer system is required to store this information and to provide a means for subsequent evaluation. MONI (Monitoring of nosocomial infections) is an intelligent database and monitoring system for surveillance and detection of nosocomial infections. Data can be entered into the system manually as well as transferred automatically from external information systems. The central feature of the system is the automatic detection of and calling attention to conditions that may be a detriment to patient recovery, such as possible hospital-acquired infections, risk factors, diseases to be reported, etc. By using this system, we seek to reduce the frequency of infection and the frequency of nosocomial deaths by improving the quality of patient treatment, shortening the length of stay in a hospital, and the use of fewer and/or cheaper antibiotics. MONI provides a means to access relevant medical data (names of infectious agents, antibiotics, department names, monitoring rules, etc.) from a library. This library can be updated or otherwise modified, even during use. An infection control team using this system can customize it to suit the demands of that particular unit. Automatic data transfer from external information systems is made possible by tables that translate between different code systems. The system also offers flexibility; the program can be configured to adapt it for use in other hospitals and institutions. The core element of MONI is the monitoring module, which is implemented as a layer between data input and the database. Upon data acquisition, the system checks the input against several monitoring tools and alerts the user to matches, which may indicate an infection risk. Processing of a rule may be deferred, depending on complexity of the rule and the actual and estimated workload of the system. Examples of the monitoring guidelines are: (1) suspicion of nosocomial infection; (2) infection at a normally sterile site; (3) infection due to bacteria with unusual antibiotic sensitivity patterns; (4) lab report indicates that patient is treated with ineffective antibiotic; (5) possible choice for less expensive antibiotic; (6) infection which is required to be reported to state and/or health authorities; (7) patients receiving prophylactic antibiotics longer than medically indicated; and (8) infections of two or more patients in different wards with the same bacteria (cf. Evans 85). The MONI system was developed at one of the largest hospitals in Europe, the Vienna General Hospital (2,200 beds). This facility serves as the teaching hospital of the University of Vienna Medical School. The size of the hospital and the large amount of data made it necessary to introduce such a system into clinical routine. MONI was programmed in C and C++ with a state-of-the-art graphical user interface (Presentation Manager, Workplace Shell) for OS/2. IBM Database 2 for OS/2 (dB 2/2) was used in constructing the database. The layer between the database and the monitoring application is driven by the multitasking and interprocess communication abilities of OS/2. A pen-based support system that assists in mobile data acquisition is currently under development.

Anti-Bacterial Agents↗

[Performance study of teleradiology network systems with CRT monitors: ROC analysis of an observation study of simulated lung nodules].

PURPOSE: To evaluate the diagnostic performance of commercially available CRT monitors used in a teleradiology system by determining the rate of detection of simulated lung nodules. MATERIALS AND METHODS: Three types of CRT monitors were tested in the observation study. They had matrix sizes of 1024 x 768(16 inches, color), 1024 x 768(20 inches, color) and 1600 x 1125(24 inches, black and white). Twenty chest radiographs were obtained by Fuji computed radiography(FCR) of an anthropomorphic chest phantom with ten simulated nodules on its surface. These FCR films were digitized by a film digitizer with 125 DPI(1024 x 1024 matrix sizes)and 12 bit gray scales, and the image data were transferred from Shinshu University Hospital to other hospitals where interpretation was carried out by the radiologists. Ten radiologists of three hospitals were asked to interpret independently both the original FCR films and the images shown on the CRT monitors and to indicate the presence or absence of simulated nodules on the images by using a five-category rating scale. Receiver operating characteristics(ROC)curves were generated, and the results of interpretation on the FCR films and CRT monitors were compared. RESULTS: Performance of the all readers was slightly better with the CRT monitors than on the FCR films, although the differences were not statistically significant. There were no statistically significant differences in performance depending on the type of CRT monitor. CONCLUSION: Performance of the CRT monitors was comparable to that of FCR radiography in terms of interpreting the simulated lung nodules.

Computer Communication Networks↗

[The electrocardiogram during physical stress and Holter monitoring in the detection of asymptomatic myocardial infarct].

INTRODUCTION: In patients with myocardial infarction acute myocardial ischaemia could be manifested by characteristic ischaemic symptoms or noncharacteristic symptoms such as cardiac insufficiency or heart rhythm disturbances. Sometimes myocardial ischaemia is not followed by any symptom. This condition is known as asymptomatic myocardial ischaemia. Asymptomatic myocardial ischaemia usually could be detected by treadmill exercise tolerance test or 24-hour Holter ECG monitoring. PATIENTS AND METHODS: We analyzed a group of 58 patients suffering from myocardial infarction with ST segment depression during the treadmill exercise tolerance test. All patients were on Holter 24-hour ECG monitoring. As a criterion of myocardial ischaemia during Holter monitoring ST segment depression of 1 mm and more, lasting 1 minute and more, and 0.08" of J point was accepted. RESULTS: During the treadmill exercise tolerance test segment depression was not followed by any symptom in 18 (31%) patients. There were no differences in the number of patients with hypertension in the group with symptoms and the group without symptoms. Diabetes mellitus was more frequent in the group with asymptomatic myocardial ischaemia. The average values of maximum ST segment depression and heart rates during treadmill tests were not statistically significant in both groups (with and without symptoms). During daily activities myocardial ischaemia was found in 30 (51%) patients by a 24-hour Holter ECG monitoring. We observed 198 episodes of myocardial ischaemia of which 138 (69.1%) were asymtomatic. The amplitude of ST segment depression and duration of these changes were significantly greater in the group with symptomatic episodes than in the group with asymptomatic episodes of myocardial ischaemia. DISCUSSION: Asymptomatic myocardial ischaemia is an often appearance in patients with myocardial ischaemia. Almost in 25% of persons in whom sudden death occurred obstructive changes in coronary arteries during the autopsy were found. Asymptomatic myocardial ischaemia could be found even an a "completely healthy person" without any complaints. Asymptomatic myocardial ischaemia is usually detected in a "completely healthy person" by casual diagnosis, in patients with stable and non stable angina pectoris, in patients with stenosis of the coronary arteries proved by angiography, and in patients after myocardial infarction. Some authors considered that treadmill exercise tolerance testing is less reliable to discover asymptomatic myocardial ischaemia comparing to the continuous 24-hour Holter ECG monitoring. It is know that in patients with diabetes mellitus neuropathy precedes the onset of symptomatic myocardial ischaemia. Asymptomatic myocardial ischaemia has the same predictive value for prognosis of the disease as symptomatic myocardial ischaemia. In some patients "anginal alarm system" is defective, and perception and conduction of pain sensations are disturbed. CONCLUSION: 1. In 31% of patients who suffered from myocardial infarction with ST segment depression during the treadmill testing asymptomatic myocardial ischaemia was found. 2. By Holter monitoring ischaemia ST segment depression during the exertion is observed in 52% of patients. Most of ischaemic episodes were asymptomatic. 3. The amplitude of ST segment depression is significantly greater and duration of depression is significantly longer in symptomatic episodes of myocardial ischaemia comparing to asymptomatic myocardial ischaemia obtained by Holter ECG monitoring.

Electrocardiography↗

Noninvasive monitoring of peripheral perfusion.

BACKGROUND: Early hemodynamic assessment of global parameters in critically ill patients fails to provide adequate information on tissue perfusion. It requires invasive monitoring and may represent a late intervention initiated mainly in the intensive care unit. Noninvasive monitoring of peripheral perfusion can be a complementary approach that allows very early application throughout the hospital. In addition, as peripheral tissues are sensitive to alterations in perfusion, monitoring of the periphery could be an early marker of tissue hypoperfusion. This review discusses noninvasive methods for monitoring perfusion in peripheral tissues based on clinical signs, body temperature gradient, optical monitoring, transcutaneous oximetry, and sublingual capnometry. DISCUSSION: Clinical signs of poor peripheral perfusion consist of a cold, pale, clammy, and mottled skin, associated with an increase in capillary refill time. The temperature gradients peripheral-to-ambient, central-to-peripheral and forearm-to-fingertip skin are validated methods to estimate dynamic variations in skin blood flow. Commonly used optical methods for peripheral monitoring are perfusion index, near-infrared spectroscopy, laser Doppler flowmetry and orthogonal polarization spectroscopy. Continuous noninvasive transcutaneous measurement of oxygen and carbon dioxide tensions can be used to estimate cutaneous blood flow. Sublingual capnometry is a noninvasive alternative for gastric tonometry.

Adult↗

Axillary nerve monitoring during arthroscopic shoulder stabilization.

PURPOSE: This study evaluated the ability of a novel intraoperative neurophysiologic monitoring method used to locate the axillary nerve, predict relative capsule thickness, and identify impending injury to the axillary nerve during arthroscopic thermal capsulorrhaphy of the shoulder. TYPE OF STUDY: Prospective cohort study. METHODS: Twenty consecutive patients with glenohumeral instability were monitored prospectively during arthroscopic shoulder surgery. Axillary nerve mapping and relative capsule thickness estimates were recorded before the stabilization portion of the procedure. During labral repair and/or thermal capsulorrhaphy, continuous and spontaneous electromyography recorded nerve activity. In addition, trans-spinal motor-evoked potentials of the fourth and fifth cervical roots and brachial plexus electrical stimulation, provided real-time information about nerve integrity. RESULTS: Axillary nerve mapping and relative capsule thickness were recorded in all patients. Continuous axillary nerve monitoring was successfully performed in all patients. Eleven of the 20 patients underwent thermal capsulorrhaphy alone or in combination with arthroscopic labral repair. Nine patients underwent arthroscopic labral repair alone. In 4 of the 11 patients who underwent thermal capsulorrhaphy, excessive spontaneous neurotonic electromyographic activity was noted, thereby altering the pattern of heat application by the surgeon. In 1 of these 4 patients, a small increase in the motor latency was noted after the procedure but no clinical deficit was observed. There were no neuromonitoring or clinical neurologic changes observed in the labral repair group without thermal application. At last follow-up, no patient in either group had any clinical evidence of nerve injury or complications from neurophysiologic monitoring. CONCLUSIONS: We successfully evaluated the use of intraoperative nerve monitoring to identify axillary nerve position, capsule thickness, and provide real-time identification of impending nerve injury and function during shoulder thermal capsulorrhaphy. The use of intraoperative nerve monitoring altered the heat application technique in 4 of 11 patients and may have prevented nerve injury. LEVEL OF EVIDENCE: Level II, prospective cohort study.

Adolescent↗

A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia.

BACKGROUND: The diagnostic utility of 24-h oesophageal ambulatory pH monitoring in patients with functional dyspepsia has not been well established. AIMS: We performed a prospective study of oesophageal pH monitoring in patients with functional dyspepsia in order to assess whether a positive pH test might predict response to proton pump inhibitor therapy in a subset of functional dyspepsia patients. PATIENTS: Forty Helicobacter pylori-negative functional dyspepsia patients (35 males and 5 females, mean age (+/-S.E.M.) of 54+/-2.4 years) with predominantly unspecified dyspepsia subtype and normal distal oesophageal biopsies. METHODS: All subjects were randomised in a double-blind fashion to either omeprazole 20 mg/day or placebo daily for four weeks after 24-h pH monitoring. RESULTS: Twenty-four-hour pH monitoring was abnormal in 9 of the 21 patients (43%) in the omeprazole group and 5/19 (26%) of the placebo group (p=NS). Patients who reported symptomatic improvement on the Gastrointestinal Symptom Rating Scale were no more likely to have abnormal scores on pH monitoring than patients who did not have symptomatic response. CONCLUSIONS: Although approximately one-third of functional dyspepsia patients will have abnormal profiles on 24-h ambulatory oesophageal pH monitoring, an abnormal score does not appear to predict response to proton pump inhibitor therapy in patients with unspecified functional dyspepsia.

Anti-Ulcer Agents↗

A randomized, controlled trial of transcutaneous carbon dioxide monitoring during ERCP.

BACKGROUND: Pulse oximetry, used to monitor oxygen saturation during endoscopy, does not directly measure hypoventilation. Study goals were to determine whether transcutaneous carbon dioxide (PtcCO(2)) monitoring during endoscopic retrograde cholangiopancreatography (ERCP) prevents severe hypoventilation and to assess the accuracy of clinical observation and pulse oximetry in detecting hypoventilation. METHODS: All patients received intensive clinical and electronic monitoring including pulse oximetry. Supplemental oxygen was administered for pulse oximetry < 90%. Patients were randomized to a treatment arm (group 1) where PtcCO(2) monitoring guided sedation or a control arm (group 2) where PtcCO(2) was recorded but unavailable for guiding sedation. RESULTS: Group 1 had significantly fewer episodes of severe carbon dioxide retention (rise in PtcCO(2) >/=40 mm Hg above baseline) than group 2 (0 of 199 versus 5 of 196, respectively, p = 0.03), as well a shorter mean duration of procedure discomfort (8.3% of procedure duration rated as "uncomfortable" versus 11.5%, p = 0.04). Correlations between clinical observation and objective measures of ventilation were poor: level of sedation versus PtcCO(2) (R = 0.3) or pulse oximetry (R = 0.06); slowest respiratory rate versus PtcCO(2) (R = 0.4) or pulse oximetry (R = -0.4). PtcCO(2) rises of greater than 20 mm Hg occurred without oxygen desaturation in 10.7% of patients receiving supplemental oxygen. CONCLUSIONS: Carbon dioxide retention during ERCP is not reliably detected by clinical observation or by pulse oximetry in patients receiving supplemental oxygen. The addition of PtcCO(2) monitoring prevents severe carbon dioxide retention more effectively than intensive clinical monitoring and pulse oximetry alone. The clinical relevancy of this observation needs to be determined in an appropriately designed outcome study.

Blood Gas Monitoring, Transcutaneous↗

Early continuous noninvasive haemodynamic monitoring after severe blunt trauma.

BACKGROUND: Invasive haemodynamic parameters obtained by pulmonary artery (PA) catheterization from survivors' patterns were reported to provide criteria for therapeutic goals in high-risk elective surgery and accidental injuries. This approach is limited because PA catheterization requires critical care conditions; however, noninvasive methods can provide early information anywhere in the hospital. OBJECTIVES: To evaluate the feasibility of using noninvasive haemodynamic monitoring of patients with severe blunt trauma immediately after emergency department (ED) admission and to describe the early time course of haemodynamic events in survivors and nonsurvivors of blunt trauma. SETTING: A large, academic, level-I trauma centre. DESIGN: Prospective, descriptive haemodynamic study. PATIENTS AND METHODS: 38 severely injured patients, 22 (58%) survivors and 16 (42%) nonsurvivors, with ISS > 15 were monitored by: (a) an improved thoracic bioelectric impedance device that estimated cardiac output noninvasively and continuously, (b) simultaneous arterial oxygen saturation by pulse oximetry, (c) noninvasive blood pressure measurement and (d) transcutaneous oxygen and carbon dioxide sensors. The patients were monitored as soon as possible upon arrival at the ED and continued during the first 24 h or more after admission. When the patient reached the ICU, monitoring by PA catheterization was undertaken to validate the noninvasive methods and for continued diagnostic evaluations. RESULTS: Cardiac output estimations by thermodilution and bioimpedance were well correlated; r = 0.91. Survivors started with high cardiac index (CI) values that subsequently rose to over 4 L/min/m2; arterial oxygen saturation (SaO2), transcutaneous oxygen tension and transcutaneous-oxygen-tension-to-inspired-fraction-of-oxygen-concentr ati on (PtcO2/FiO2) values were normal in survivors and higher than those of the nonsurvivors. In the 1st h after admission, nonsurvivors' blood pressures were higher than normal and higher than that of the survivors, but in the 2nd and 3rd h, both groups were in the normal range; thereafter, nonsurvivors' values were lower than survivors' and often lower than normal. CONCLUSIONS: The noninvasive haemodynamic monitoring system provides reasonably accurate, continuous, on-line, real-time display of haemodynamic data that show marked differences in the early patterns of survivors and nonsurvivors. The study suggests noninvasive monitoring may be used for early detection and correction of posttraumatic circulatory deficits.

Adult↗

Low reproducibility of 2 x 24-hour continuous esophageal pH monitoring in infants and children: a limiting factor for interventional studies.

The aim of this study was to investigate the day-to-day reproducibility of 24-hr esophageal pH monitoring. The procedure was performed continuously for 48 hr in order to enable future studies on dietary challenges, using consecutive 2 x 24 hr pH recording. Furthermore, one objective was to relate the degree of reproducibility to endoscopic evidence of mucosal injury. Upper endoscopy and 2 x 24-hr consecutive pH monitoring were performed in 30 infants and children referred for gastroesophageal reflux disease. The monitoring was performed without dietary or activity restrictions in order to assess reflux parameters in a near-normal physiologic setting. The NASPGHAN criteria for pathological reflux index (RI, % fraction of time with pH < 4.0) were employed. Based upon the NASPGHAN criteria for the RI, 9/30 subjects (30%) had discordant (normal vs pathologic) results at the two recording days, yielding an overall reproducibility of 70%. The limits of agreement for RI at day 2 were 0.2-3.3 times the initially obtained value at day 1. No difference was found in terms of reproducibility between groups with and without esophageal mucosal changes (erythema and esophagitis). No significant difference was noted in the association between pH monitoring and macroscopic esophageal mucosal changes between the two recordings days. In conclusion, a considerable intraindividual variability in reflux parameters was observed between the measurements from day 1 to day 2. This physiologic variability should be taken into consideration when evaluating gastroesophageal reflux disease in infants and children by means of pH monitoring. The day-to-day variability limits the use of simultaneous pH monitoring and dietary challenges as a procedure to identify a possible causative relation between GERD and dietary allergy/intolerance.

Adolescent↗

Comparison of transcutaneous and endtidal CO2-monitoring for rigid bronchoscopy during high-frequency jet ventilation.

OBJECTIVE: To compare endtidal and transcutaneous respiratory monitoring of high-frequency jet ventilation (HFJV) in rigid bronchoscopy. Both techniques provide a noninvasive measurement of pCO2. METHODS: High-frequency jet ventilation was applied via a rigid bronchoscope. Driving pressure (DP) was initially adapted to ensure normal ventilation. It was then changed twice by +/- 30% from the initial value. Endtidal and transcutaneous data were compared with arterial blood gas monitoring (ABG). RESULTS: Results were analyzed separately for the time just after changing the driving pressure (10 min) and the remaining time until the next change of the driving pressure (4 min). The first part was called the dynamic phase, and the second part the steady-state phase. Correlation coefficient between endtidal capnography and ABG was 0.96 for the steady state and 0.94 for the dynamic phase, respectively. Bland-Altman analysis revealed a bias of -0.21 kPa with limits of agreement (LOA) 1.63 kPa for the steady state and -0.25 kPa, 2.08 kPa for the dynamic phase, respectively. Correlation coefficient between transcutaneous monitoring and ABG for the steady state phase was 0.83, and was 0.72 for the dynamic phase. Bland-Altman analysis resulted in a bias of -0.89 kPa with LOA - 3.84 kPa during steady state and 0.92 kPa, 4.06 kPa for the dynamic phase, respectively. CONCLUSION: Endtidal capnography offers accurate respiratory monitoring of HFJV. Transcutaneous monitoring showed a good correlation to ABG only during steady-state conditions. For the dynamic phase the accuracy was significantly lower. Thus, we cannot recommend transcutaneous respiratory monitoring for the specific indication of rigid bronchoscopy using HFJV.

Adult↗

Video-EEG monitoring in adults.

The routine EEG study may prove inadequate in selected patients with recurrent and unprovoked seizures. Video-EEG monitoring is an important diagnostic innovation that may be used to confirm the diagnosis of a seizure disorder and classify seizure type. The methodologies and clinical applications of video-EEG monitoring are reviewed. Long-term EEG recordings may be performed as an outpatient or in an epilepsy monitoring unit. Potential techniques for video-EEG monitoring include prolonged conventional routine EEG, ambulatory EEG, and computer-assisted EEG recordings. Periictal SPECT studies performed during long-term EEG recordings in the epilepsy monitoring unit may increase the diagnostic yield of a presurgical evaluation. Video-EEG monitoring is essential for surgical localization in patients with intractable partial epilepsy being considered for a focal cortical resection. The studies may also be necessary to confirm the presence of nonepileptical clinical episodes.

Adolescent↗

Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.

The aim of this study was to determine the prevalence and extent of glycemic excursions (hypo- and hyperglycemic) in elderly patients with well-controlled type 2 diabetes using a Continuous Glucose Monitor System (CGMS) (Medtronic MiniMed). Elderly patients (>65 years old) with type 2 diabetes were recruited if their glycosylated hemoglobin (HbA1c) was <7.5% and if their oral hypoglycemic therapy included a sulfonylurea. Patients were asked to undergo two consecutive 72-h periods of continuous glucose monitoring at baseline and then again at 1 month (total 288 h). Patients were asked to record four self-monitored capillary blood glucose levels each day for calibration of the monitor and also to record meal times, exercise, and symptoms of hypoglycemia. The number of hyperglycemic (>144 mg/dL), hypoglycemic (<50 mg/dL), and borderline-hypoglycemic (50-65 mg/dL) events were determined (an event was defined as a glucose value that persisted for at least 15 min with or without symptoms). Twenty-five patients (21 men, four women) 73.9 +/- 4.4 years old with an HbA1c of 6.2 +/- 0.8% were each monitored for an average of 187.57 h. The mean glucose values were: fasting, 139 +/- 40 mg/dL; 2 h post-breakfast, 167 +/- 58 mg/dL; 2 h post-lunch, 157 +/- 53 mg/dL; and 2 h post-dinner, 149 +/- 49 mg/dL. Twenty patients (80%) experienced a total of 103 hypoglycemic events, and 14 of these patients experienced 54 events where the glucose levels were </=40 mg/dL. Twenty-four patients (96%) experienced borderline-hypoglycemia (n = 229 events). Patients experienced a mean of 0.62 +/- 0.72 episodes of hypoglycemia (interstitial glucose <50 mg/dL) per day (four to five episodes overall), 0.35 +/- 0.6 episodes per day where the interstitial glucose was </=40 mg/dL (two to three episodes overall), and 1.37 +/- 1.22 episodes of borderline-hypoglycemia (nine to 10 episodes overall). Each episode of hypoglycemia persisted for 78 +/- 73 min, and borderline-hypoglycemia for 45 +/- 11 min. Patients were hypoglycemic 3.3% of the time and borderline-hypoglycemic 3.7% of the time. No episode of hypoglycemia was recorded by any patient in his or her daily diary. High postprandial glucose values (>144 mg/dL 2 h postprandial) were recorded after 57% of all meals (breakfast 60%, lunch 57.5%, dinner 55.2%). The CGMS was generally well tolerated, but 52% of patients could not be studied for the full 12 days of monitoring. Thus hypoglycemia and excessive postprandial glycemic excursions are common in well-controlled patients with type 2 diabetes treated with a sulfonylurea with or without metformin. The CGMS is a useful research and clinical tool to assess glycemia in patients with type 2 diabetes but is not tolerated by all subjects.

Aged↗

Tolerance and reliability of wireless pH monitoring in children.

OBJECTIVES: The purpose of this study was to determine whether the placement of a wireless capsule pH monitoring system improved the reproducibility and patient comfort of pH probe studies in children. METHODS: The records of 50 children who underwent wireless pH monitoring were retrospectively reviewed. Among this group, 44 children (27 males and 17 females) met inclusion criteria. The average age was 11.8 years, with a range from 6 years to 19 years. Each of these patients had a capsule placed 6 cm above the squamocolumnar junction and underwent pH telemetry for 2 days. In addition, 38 of the 44 families were contacted for follow-up to determine the tolerability of the catheter-free monitoring. RESULTS: Data analysis revealed that the overall reproducibility of a single 24 hour period was 77%. Studies were considered reproducible if the reflux index was normal (pH <4 for less than 5% of study period) or abnormal on both study days. Using McNemar's exact test, we found no significant difference between the two days (P = 0.11). Ten of 44 patients had conflicting results on day 1 compared with results on day 2. The majority (68%) of patients reported some degree of discomfort during the study; however, this pain was generally mild. Ninety-five percent of parents would be willing to have their child undergo pH monitoring in the future with the wireless pH monitoring. CONCLUSIONS: Catheter-free prolonged esophageal pH monitoring is feasible in children older than 6 years of age. A lack of consistent reproducibility in sequential 24 hour recordings with this technique concurs with findings using the conventional catheter methodologies. The catheter-free system is often associated with discomfort during the study, but these symptoms were generally well tolerated.

Adolescent↗

Telephone-guided placement and removal of nicotine monitors for the assessment of passive exposure to environmental tobacco smoke.

The aim of this study was to determine the feasibility of telephone-guided placement of nicotine air sampling monitors in homes of women with infants. A monitor was mailed to homes in which the mother, her partner, or both were smokers, and a research assistant telephoned the woman and guided her through proper placement of the monitor according to a standard protocol. To assess the success of the guided placement, research assistants visited the homes of 50 women at the end of the two-week air-sampling period. The placement was determined to be correct if the monitor was positioned at least 1 ft from windows, more than 1 ft from the nearest corner of the room, and more than 2 ft from ashtrays. We had a 94% success rate for monitor placement in our study population, and our cost assessment showed that guided placement and removal cost approximately one-tenth the amount of methods requiring research assistants to conduct placements onsite. These results suggest that telephone-guided placement of monitors is an acceptable, inexpensive alternative to onsite placement by research assistants.

Costs and Cost Analysis↗

Recommendations for the monitoring of short-term health effects of air pollution: lessons from the APHEA Multi Centre European Study.

Accumulating evidence from European cities indicates that current levels of ambient air pollution are likely to be associated with detectable effects on daily mortality and hospital admissions. Public health authorities everywhere are concerned about the possible effects of air pollution on the health of their populations but there are no guidelines for how these effects can efficiently be monitored. Furthermore, decisions about air pollution monitoring tend to be made without reference to the epidemiological requirements of health monitoring. The APHEA project (Air Pollution and Health a European Approach) investigated the short-term health effects of air pollution in 15 European cities. Experience gained in this project provides a basis for recommendations to public health and environmental authorities concerning the requirements for a basic health monitoring system. This paper considers the theoretical and practical aspects of a monitoring system and makes recommendations concerning 1) the minimum data set required, 2) the methods of statistical analysis and presentation and 3) Europe-wide coordination of monitoring.

Air Pollution↗

Monitoring for neuroprotection. New technologies for the new millennium.

Monitoring for neuroprotection, like surgery, has placed on emphasis on minimal or non-invasiveness. Monitoring of parameters that truly reflect the degree of injury to the nervous system is another goal. Thus, two themes for the coming decade in neuromonitoring will be: (1) less-invasive monitoring; and (2) parameters that more closely reflect the etiological factors in ischemic or other neuroinjury. In this paper, we review neuromonitoring techniques and devices that can be used readily in the operating room or intensive care unit setting. Those that require transport of the patient to a special facility (e.g., for computed tomography or magnetic resonance imaging/spectroscopy) and those that have been in standard practice for neuromonitoring (e.g., electrophysiological monitoring--EEG, evoked potentials) are not considered. The two techniques considered in detail are (1) continuous multiparameter local brain tissue monitoring with microprobes, and (2) non-invasive continuous local brain tissue oxygenation monitoring by near infrared spectroscopy. Both techniques have been cleared by the Food and Drug Administration (FDA) for clinical use. The rationale for their use, the nature of the devices, and clinical results to date are reviewed. It is expected that both techniques will gain wide acceptance during the coming decade; further advances in neuromonitoring that can be expected further into the twenty-first century are also discussed.

Automation↗